BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9458580)

  • 21. Evaluation of a surveillance programme for women with a family history of breast cancer.
    Reis MM; Tavakoli M; Dewar J; Goudie D; Cook A; McLeish L; Young D; Kenyon J; Steel M
    J Med Genet; 2009 May; 46(5):319-23. PubMed ID: 19279022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese.
    Xie F; Luo N; Blackhouse G; Goeree R; Lee HP
    Int J Technol Assess Health Care; 2008; 24(1):87-95. PubMed ID: 18218173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer; 2008 Mar; 112(5):1058-65. PubMed ID: 18186497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of influenza vaccination in working-age cancer patients.
    Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
    Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions?
    Wang PE; Wang TT; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S54-8. PubMed ID: 17227644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
    Gupta OP; Brown GC; Brown MM
    Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decision-analytical model with lifetime estimation of costs and health outcomes for one-time screening for abdominal aortic aneurysm in 65-year-old men.
    Henriksson M; Lundgren F
    Br J Surg; 2005 Aug; 92(8):976-83. PubMed ID: 16034844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer.
    Maeda T; Cannom RR; Beart RW; Etzioni DA
    J Clin Oncol; 2010 Mar; 28(7):1175-80. PubMed ID: 20124166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost and value considerations in screening for oral cancer and precancer.
    Downer MC; Speight PM
    Community Dent Health; 1993 Jun; 10 Suppl 1():71-8. PubMed ID: 8402311
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of health care workers' accuracy in recognising oral cancer and pre-cancer.
    Jullien JA; Downer MC; Speight PM; Zakrzewska JM
    Int Dent J; 1996 Aug; 46(4):334-9. PubMed ID: 9147121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a screening test for the early detection of oral cancer and precancer.
    Jullien JA; Downer MC; Zakrzewska JM; Speight PM
    Community Dent Health; 1995 Mar; 12(1):3-7. PubMed ID: 7697560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health gain from restorative dental treatment evaluated by computer simulation.
    Downer MC; Moles DR
    Community Dent Health; 1998 Mar; 15(1):32-9. PubMed ID: 9791613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of primary health care workers for early detection of oral cancer and precancer cases in Sri Lanka.
    Warnakulasuriya KA; Ekanayake AN; Sivayoham S; Stjernswärd J; Pindborg JJ; Sobin LH; Perera KS
    Bull World Health Organ; 1984; 62(2):243-50. PubMed ID: 6610492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for disease: making evidence-based choices.
    Fields MM; Chevlen E
    Clin J Oncol Nurs; 2006 Feb; 10(1):73-6. PubMed ID: 16482730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of measures of effectiveness in screening for oral cancer and precancer.
    Downer MC; Moles DR; Palmer S; Speight PM
    Oral Oncol; 2006 Jul; 42(6):551-60. PubMed ID: 16815505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.